Already out yesterday.
http://aasld2011.abstractcentral.com/planner.jsp
and go to 'search' in the left side menu.
eg: http://aasld2011.abstractcentral.com/planner?NEXT_PAGE=ITINERARY_ABS_DET_POP&SESSION_ABSTRACT_ID=847072&ABSTRACT_ID=1135482&SESSION_ID=90705&PROGRAM_ID=2911
"PSI-7977 200mg or 400mg QD with PEG/RBV demonstrated potent on-treatment antiviral activity in treatment-naïve patients with HCV GT1. Greater efficacy of 400mg over 200mg is demonstrated by, three viral breakthroughs (between Wk12 and Wk24 while receiving PEG/RBV) and 1 relapse in the 200mg group, compared with no breakthrough or relapse in the 400mg group. Complete SVR12 data will be presented."